TMPRSS2-ERG is the frequent ERG gene rearrangement observed in prostate cancer and SLC45A3 is the second most common ERG partner in prostate cancer and in most of patients SLC45A3-ERG rearrangements co-occur with TMPRSS2-ERG rearrangements [11]. Here, SLC45A3 is linked to prostate carcinoma.